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Background: Depression is a common comorbidity in individuals with cognitive impairment. Those with cognitive
impairments face unique challenges in receiving the benefits of many conventional therapies for depression, and may
have poorer outcomes in areas such as recovery and quality of life. However, the stigmatization of mental health
disorders, cost barriers and physical disabilities may prevent these individuals from seeking mental health care. An
online, self-help intervention specifically developed for adults with cognitive deficits and depression may be particularly
beneficial to this population. We aim to inform the design of such an intervention through a systematic review by
answering the following research question: among adults with cognitive impairment (including those with acquired
brain injuries or neurodegenerative diseases), which technology-amenable interventions have been shown to effectively
decrease symptoms of depression? Specifically, psychotherapeutic and/or behavioural interventions that could be
delivered in a self-guided, online system will be included.
Methods: Comprehensive electronic searches will be conducted in MEDLINE, EMBASE, PsycINFO and CINAHL.
Additional studies will be obtained through manually searching the references of relevant systematic reviews,
contacting primary authors of select articles and tracking conference proceedings and trial registries. Article titles
and abstracts will be screened using predefined eligibility criteria, and then judged for their amenability to the
proposed self-help, technology-based intervention. The full text of those articles with selected interventions will
then be screened to determine final eligibility for inclusion. Included articles will be categorized by intervention
type and assessed for risk of bias using the Cochrane Effective Practice and Organization of Care Risk of Bias tool
for non-randomized trials, controlled before-after studies and interrupted time series. The primary outcome will
be a change in score on a validated depression scale, and adverse events will be documented as a secondary
outcome. After data extraction from selected articles, pooling of data and meta-analysis will be conducted if a
sufficient pool of studies with comparable methodology and quality are identified. Alternatively, plain language
summaries will be developed. The quality of evidence will be assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) system.
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The link between depression and cognitive impairment
Depression is a common mental health issue faced by
individuals who experience injuries to the brain and may
consequently experience cognitive impairments. Such in-
juries may result from, for example, acquired brain injuries
(e.g. traumatic brain injury (TBI), stroke) or neurodegen-
erative diseases (e.g. mild cognitive impairment (MCI), de-
mentia, Alzheimer’s disease (AD)). Approximately one
third of older adults with early-phase dementia experience
depressive symptoms [1]. The prevalence of clinical de-
pression is estimated at 17% in patients with AD [2],
15.7% to 44.3% in individuals with MCI [3] and 10% to
77% among TBI survivors [4,5]. Furthermore, these de-
pressive symptoms have been shown to be associated with
impaired cognitive functioning [6].
The precise relationship between depression and cog-
nitive impairment has not yet been concretely defined.
On one hand, depression may be considered a risk factor
for cognitive impairment [7]. The potentially reversible
cognitive decline that accompanies depression has been
previously referred to as ‘pseudodementia’ [8], and has
been shown to increase the likelihood of developing irre-
versible dementia in later life [9,10]. One mechanism
that may explain this process is the idea that the altered
thinking patterns in depression, such as experiencing re-
curring negative thoughts, may overload executive func-
tioning and thereby contribute to cognitive deficits [11].
Conversely, it has been argued that cognitive impair-
ment is a risk factor for depression [12]. This is based
on the hypothesis that diminished cognitive capacities
may alter an individual’s perception of their surround-
ings, leading to depressive thoughts [11,13]. Although
the relationship between depression and cognitive im-
pairment is not yet elucidated, it is apparent that the
two conditions are interconnected.
Among patients with brain injuries, the combination of
injury-related and psychosocial factors may also play a role
in the progression of depression. Injury-related factors that
may lead to depression include changes in brain neuro-
transmitter levels, genetic factors, neuroendocrine changes
or lesions to particular brain regions [14]. Cognitive
impairment may impede social interactions and the return
to normal activities, resulting in a situation conducive to
depression [13].
Impact of depression in cognitively impaired adults
Untreated depression, especially in individuals with cog-
nitive impairments, can negatively impact a wide range
of outcomes. Depression can give rise to disruptive and/
or aggressive behaviour, leading to increased caregiver
burden, higher rates of caregiver depression and prema-
ture nursing home placement [14]. Individuals with
depression are also three times less compliant in theadherence to medical regimens in chronic illness com-
pared to those without depression [15]. Furthermore, de-
pression may hinder cognitive recovery by exacerbating
neuropsychological impairment [16,17]. Depression in
individuals with TBI can lead to worse global outcomes
[18], worse social functioning [19,20], lower health-
related quality of life including an inability to return to
work [21,22] and suicide [23]. These poor outcomes
have significant societal costs: in industrialized countries
like Canada and the USA, it is estimated that 2% of the
population live with lifelong disabilities resulting from
TBI and roughly one in four adults with TBI are unable
to return to work 1 year after injury because of physical
or mental disabilities [24]. As such, incorporating
treatments for depression while addressing cognitive
impairments may have a wide range of positive effects
on outcomes for this patient population.
The use of technology for the treatment of depression
Unfortunately, many individuals do not receive adequate
treatment for mental health issues such as depression.
Even when access to a mental health practitioner is
available, many individuals do not seek treatment
[25-27]. This may occur due to the negative stigma sur-
rounding depression and other mental health conditions,
for the preservation of privacy concerning personal mat-
ters, or because depression may not be perceived as a
priority for treatment in individuals suffering from other
comorbidities. Furthermore, there may be limited re-
sources available to treat depression, particularly among
those with cognitive impairments who may already be
heavily utilizing the healthcare system (e.g. nursing
home residents).
Technology-delivered (e.g. the internet, mobile plat-
forms) self-help treatment approaches for depression
may be more accessible for individuals as they can be
used in the privacy of one’s home on their own schedule
and pace, have no waitlist and may be more economical.
Such tools would also overcome transportation-related
obstacles faced by individuals with cognitive impair-
ments and co-occurring injuries or physical disabilities.
While internet-based programs currently exist for treat-
ing depression among general community samples, they
have not been designed to consider the specific needs of
individuals with cognitive impairments [28]. For ex-
ample, although completion of the internet-based Mood-
Gym training program was associated with decreased
symptoms of depression among a sample of individuals
who had experienced TBI, the participants reported dif-
ficulties with reading, memory and attention when using
the program [29]. Such issues were reiterated in a separ-
ate study of patients with TBI who reported that they ex-
perience cognitive limitations such as reduced memory,
attention, concentration, and deficits in visual acuity
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technology-based therapies (unpublished observations).
Patient feedback regarding such therapies included sim-
plifying instructions, allowing for sufficient breaks be-
tween and within modules, reducing the amount of text
and incorporating more user-friendly layout and designs
(unpublished observations). Thus, there is an opportunity
and need for developing an evidence-based technology-
delivered intervention for depression customized to the
needs of adults experiencing cognitive impairments.
Objective and aims of the review
Previous research has shown that currently existing
internet-delivered programs are not adapted to the specific
needs of individuals with cognitive impairments, par-
ticularly with respect to impaired cognitive processing
(e.g. attention, memory and executive function) [29].
To address this gap, our study team is developing a
new treatment approach, namely, a self-help, treatment
program for patients with cognitive impairment and
depression which will be delivered via technologies such
as the internet or mobile platforms (e.g. telephone, tablet
computers).
The objective of this systematic review is to inform the
design of such an intervention by answering the following
research question: among adults with cognitive impairment
(including those with acquired brain injuries or neurode-
generative diseases), which technology-amenable interven-
tions have been shown to effectively decrease symptoms of
depression? Interventions that will be considered amenable
to our proposed technology-delivered intervention are be-
havioural or psychotherapeutic interventions that can be
applied to different individuals in a standardized manner
using a manualized approach.
Three specific aims will be addressed in order to
meet the overarching objective of this review. The first
aim is to identify potential interventions that can be
adapted for use with technology by patients with cogni-
tive impairment and depression. This will be accom-
plished by employing broad selection criteria and being
inclusive of a wide range of studies across different
clinical populations. Second, we will identify which in-
terventions have been shown to effectively treat depres-
sion in adults with cognitive impairment. This will be
accomplished through a structured synthesis of the
identified studies. Finally, the risk of bias and quality of
evidence assessments will aide in identifying areas of
strength and limitations in the existing body of litera-
ture, and we will identify potential gaps in the literature
to inform future studies. Such gaps could include a lack
of evidence regarding the efficacy of a particular interven-
tion type, the efficacy of a given intervention with certain
populations or with patients at varying levels of cognitive
impairment, a lack of assessment of adverse events orlong-term follow-up related to an intervention, a lack of
research on specific outcomes (e.g. clinician diagnosed
major depression versus self-reported symptoms of de-
pression; comorbid conditions such as anxiety) and/or as-
sessment of cost-effectiveness.
Collectively, the outputs from this review will ad-
vance health-related knowledge and health research.
The results of this systematic review will advance
knowledge in the area of treatment approaches for de-
pression in individuals with cognitive impairment by
identifying treatment approaches that have been shown
to be effective with this population. While there exist
literature reviews of interventions for depression and/
or anxiety within the proposed patient populations
[30-35], no review, which we are aware of, has looked
at interventions that cut across various clinical popula-
tions, and focus on the issue of cognitive impairment,
rather than the clinical condition. Thus, there is an oppor-
tunity to translate findings from potentially disparate con-
ditions to each other. Additionally, by identifying gaps in
the research, this review can help inform healthcare
practitioners about the state of current evidence, and
also help develop recommendations for future research
in this field. In the long-term, this review will also in-
form the development of a novel technology-delivered
intervention which will aim to improve the health out-
comes of individuals with cognitive impairment who
also live with depression.
Methods/design
Study registration
This protocol is registered with PROSPERO
(CRD42014014417).
Types of study designs
A systematic review will be conducted in accordance
with the Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) statement recom-
mendations [36]. As classified by the Cochrane Effective
Practice and Organization of Care [37], randomized con-
trolled trials (RCT), non-randomized controlled trials,
controlled before-after designs and interrupted time
series studies (including repeated measures studies) will
be included in the structured analysis and synthesis.
Non-comparative studies (case series) and before-after
studies without multiple measurements before and after
the intervention will be captured and summarized in a
separate appendix, but not formally analysed. Non-RCTs
will be included as 1) our scoping searches identified
only a few RCTs, and 2) we do not want to exclude any
potential interventions of interest. We are not aiming to
identify only one, best intervention but rather the range
of possible ones to consider for implementation in the
planned intervention program. Articles published in the
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cluded whereas abstracts, review articles, cohort designs or
case series with five or less participants will be excluded.Types of participants
Studies will be considered for inclusion in this systematic
review if they assessed adults with cognitive impairment
as demonstrated using validated cognitive measures.
Studies of populations with cognitive impairments due to
factors other than neurodegenerative disease or acquired
brain injuries (e.g. congenital disorder, fetal alcohol syn-
drome or developmental disability from cerebral palsy,
muscular dystrophy, autism, and spina bifida with hydro-
cephalus) will be excluded.Types of interventions
Studies which assessed a behavioural/psychotherapeutic
intervention or treatment will be included in the review.
This may include 1) cognitive rehabilitation (e.g. memory
training, cognitive stimulation therapy, cognitive training,
neuropsychological training, neurorehabilitation), 2) psy-
chotherapy (e.g. cognitive behavioural therapy, interper-
sonal therapy, problem-solving therapy, supportive therapy,
counselling, social skills training), 3) psychoeducation, 4)
exercise/physical activity and 5) others. Studies will be ex-
cluded if they assessed interventions involving the adminis-
tration of a drug or procedure (e.g. acupuncture, deep brain
stimulation, electroconvulsive shock therapy, sense-based
therapy) which are not amenable to adaptation for delivery
by internet or mobile technologies or those that did not
clearly define the intervention (e.g. studies examining
multi-disciplinary clinic use).
Studies that meet the aforementioned criteria will
subsequently undergo a secondary screening phase in
which the interventions investigated will be assessed
for amenability to technology. Specifically, psychothera-
peutic and/or behavioural interventions that can poten-
tially be delivered in a self-guided, automated format
will be considered amenable for delivery via technology.
Specific criteria will be used to define whether an inter-
vention is amenable to technology as follows: 1) it must
follow a manual, protocol, or systemic approach in
order to deliver a structured form of treatment consist-
ently to all patients; 2) it must not rely on group dis-
cussion, group interaction, or therapeutic interaction;
and 3) it must not be highly individualized or catered
towards individual patients’ unique problems or life
histories. Those studies considered amenable to tech-
nology will be included in the review, whereas those
studies considered not amenable to technology will not
be included in the review but may be referred to in the
discussion. A second reviewer will confirm that a study
intervention meets these secondary criteria, and anydisagreements will be resolved through discussion and
establishing a consensus.
Note that interventions that could be systematically
customized for individual patients in terms of difficulty
level will not be excluded, as this feature can be imple-
mented into a technology-based format. Interventions in
which altering behaviour is not the primary focus of
treatment (e.g. cognitive training) will also be considered
for inclusion. Interventions incorporating feedback will
also be considered for inclusion as feedback can be auto-
mated using a technology format.
Types of controls
Control conditions could include comparator interven-
tions/treatments, usual care or waitlist. There will be no
exclusions for comparator interventions (i.e. may or may
not be amenable to technology). As indicated above, non-
comparator studies (e.g. case series) or before-after studies
without multiple measurements before and after the inter-
vention will be captured in a separate appendix to be in-
clusive of potential interventions; however, these studies
will not be used to calculate pooled estimates and will not
be subject to a separate risk of bias assessment.
Types of outcomes
Eligible studies will have assessed depression or depres-
sive symptomatology pre- and post-intervention using a
validated assessment tool. Note that depression will not
need to be the primary goal of treatment in the study. A
validated assessment tool could include any self-
reported or interviewer-administered scale (e.g. Center
for Epidemiological Studies Depression Scale [38], Beck
Depression Inventory [39]) or clinician diagnosis based on
standard diagnostic criteria (e.g. DSM-IV definition [40]).
Secondary outcomes will include any reported adverse
events associated with the interventions.
Information sources
Searches will be conducted using the following elec-
tronic databases: PubMed including MEDLINE records,
CINAHL, EMBASE and PsycINFO. In addition, refer-
ence lists of systematic reviews and relevant papers will
be manually searched. The lead author on all included
studies and other experts in the field will be contacted
to request details of any further published or unpub-
lished studies (i.e. in press). Proceedings of key confer-
ences will also be tracked as well as trial registries to
identify additional unpublished studies.
Search strategy
Broad search terms will be applied to electronic data-
bases corresponding to each of the listed inclusion cri-
teria. Search terms related to cognitive impairment
include ‘cognitive deficits’ and those relating to organic
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‘acquired brain injury’, ‘aging’ and ‘dementia’. In order to
narrow down to articles with technology-adaptable inter-
ventions, articles with interventions utilizing drugs and
procedures will be excluded by specifying exclusion terms
such as ‘antidepressants’, ‘pharmacotherapy’, ‘surgery’, ‘elec-
troconvulsive therapy’ or ‘deep brain stimulation’. Lastly,
variations of the term ‘depression’ and the names of vali-
dated depression tools will be included in the search.
Limits will be applied to find articles published in English
and conducted on humans. Complete search strategies for
each database are outlined in Table 1.
Title and abstract screening
After records are identified through the electronic
search, titles will be screened for relevancy. Abstract
screening will be conducted in two phases. In the first
phase, the abstracts of articles with relevant titles will be
screened using the primary selection criteria. In the
second phase, the abstracts will be more closely screened
using the secondary selection criteria, which involves
assessing whether interventions are amenable to tech-
nology. Articles with unclear interventions will be fur-
ther assessed during the full-text-screening step.
Full text screening
The full text of the selected articles will be screened in de-
tail for inclusion using a piloted form (Additional file 1)
that addresses each of the primary and secondary selection
criteria. The results of the full-text screening will also be
assessed by a second reviewer to confirm inclusion of arti-
cles, and any disagreements will be resolved through dis-
cussion and establishing a consensus.
During full-text screening, the inclusion/exclusion cri-
teria of each study will be evaluated in detail in order to
assess whether the study participants had cognitive im-
pairment. This criterion will be met if the mean score of
the study sample on a validated cognitive measure is
below a published cut-off score for normal cognitive
function. Diagnostic rating scales to establish the diag-
nosis of a cognitive disorder (e.g. dementia) will be con-
sidered as valid cognitive measures. For cognitive
measures that do not have cut-off scores specified, a
study will be included if the scores of participants on the
cognitive measure fall at least one standard deviation
below published normative scores for the appropriate
age range. Studies that mentioned the use of a cognitive
measure in their inclusion criteria, but did not publish
the cognitive measure data from the population prior to
implementation of the intervention will be excluded.
The methodology of each study will be assessed in order
to confirm whether a validated measure for depression
was applied to the sample in the study pre- and post-
intervention. Studies that mentioned the use of adepression measure but did not present the data and/or
results of these measures will be excluded. The amen-
ability of an intervention to technology will be assessed
by reviewing the description of each study’s methods.
Discussion between two reviewers will be used to estab-
lish a consensus regarding whether or not an interven-
tion is amenable to technology based on the secondary
selection criteria.
A flowchart outlining the full study selection process
is shown in Figure 1.
Data extraction
Data will be extracted from each article as follows: study
design, details of the intervention (name, goal, format,
duration, whether caregivers were involved and descrip-
tion of structure), details of the control condition (where
applicable), sample characteristics (inclusion and exclusion
criteria, indication of cognitive impairment at baseline,
presence or absence of clinical depression at baseline,
mean age, percentage of males and sample size) and de-
pression outcomes (depression scale used, within-group
and between-group results and results from follow-up
where applicable). Notes will also be made of any key in-
terpretations made by the authors. See Additional file 2
for the piloted data extraction form.
Assessment of risk of bias and methodological quality
Due to the wide range of study types to be included in
the review, the Cochrane Effective Practice and
Organization of Care Risk of Bias Tool [41] will be used
to assess for bias in RCTs, non-randomized controlled
trials, controlled before-after studies and interrupted
time series studies. The tool will be used to categorize
each study into low, high or unclear risk of bias for the
main outcome (depression score) on each of the nine
standard domains (seven for interrupted time series
studies), across domains and across studies as guided by
the tool. Two raters will independently apply the tool to
all studies and inter-rater reliability will be measured.
Any discrepancies will be discussed to achieve consen-
sus. Risk of bias tables will be generated for each study
and summarized in a figure using RevMan.
Data analyses
Each study will be summarized in a table indicating its
study design, sample size, study population (clinical condi-
tion in the sample, mean age, sex), intervention (name,
goal, content and structure), control/comparison groups
(where applicable; their name and brief description) and
the results of the study (pre- and post-scores on the de-
pression outcome measure). The primary outcome of
‘depression score’ will be analysed as a continuous vari-
able. Standardized mean differences (SMD) with 95% CI
will be calculated as it is anticipated that studies will use
Table 1 Database-specific search strategies
Database Detailed search terms
PubMed ((((((((((((((((((((((((‘beck depression inventory’) OR ‘zung self rating depression scale’) OR ‘patient health questionnaire 9 depression scale’)
OR ‘phq 9’) OR ‘structured clinical interview for dsm’) OR ‘scid’) OR ‘hamilton rating scale for depression’) OR (‘hospital anxiety and
depression scale’)) OR ‘minnesota multiphasic personality inventory’) OR ‘diagnostic interview schedule’) OR ‘brief symptom inventory’)
OR ‘short form 36 health survey’) OR ‘sf 36’) OR ‘neurobehavioural functioning inventory’) OR ‘composite international diagnostic interview’)
OR ‘cidi’) OR ‘present state examination’) OR ‘center for epidemiological studies depression scale’) OR ‘cesd’) OR ‘self rating scale’) OR ‘brief
symptom inventory’)) AND ((((((((((((((((((((((‘cognition disorder’ OR ‘cognition disorders’ OR ‘cognition dysfunction’))) OR ((‘cognitive defect’
OR ‘cognitive defects’ OR ‘cognitive deficiencies’ OR ‘cognitive deficiency’ OR ‘cognitive deficient’ OR ‘cognitive deficit’ OR ‘cognitive deficits’
OR ‘cognitive deterioration’))) OR ‘alzheimer’) OR ‘alzheimer disease’) OR ‘brain damage’) OR ‘brain injury’) OR exp AND ‘dementia’) OR
((‘neurodegenerative’ OR ‘neurodegenerative brain diseases’ OR ‘neurodegenerative brain disorder’ OR ‘neurodegenerative brain disorders’ OR
‘neurodegenerative dementia’ OR ‘neurodegenerative dementia diseases’ OR ‘neurodegenerative disease’))) OR ((‘mini mental state’ OR ‘mini
mental state exam’ OR ‘mini mental state exam mmse’ OR ‘mini mental state exam mmse score’)))) OR ‘stroke’) OR ‘cerebrovascular accident’)
OR ‘cerebrovascular disorder’)) NOT (((((((‘drug therapy’) OR ‘surgery’) OR ‘drug’) OR ‘acupuncture’) OR ‘light modification’) OR ‘telestroke’)))
AND depress*[Title/Abstract])) NOT ‘case report’)) NOT ‘caregiver’))) AND ((((‘therapy’) OR ‘intervention’) OR ‘psychotherapy’) OR ‘treatment’)
PubMed (((((((((((((((((((((((((((((((‘traumatic brain injury’) OR ‘cognitive impairment’) OR ‘cognitive defect’) OR ‘cognitive deficit’) OR ((‘cognitive
deficiencies’ OR ‘cognitive deficiency’))) OR ‘alzheimer’) OR ‘dementia’) OR ‘parkinson’) OR ‘neurodegenerative disease’) OR ‘mmse’)
OR ‘mini mental state exam’)) AND depress*[Title/Abstract]) AND (((((‘treatment’) OR ‘intervention’) OR ‘program’) OR ‘self help’) OR
‘therapy’)) NOT ‘deep brain stimulation’) NOT ‘electroconvulsive’) NOT ‘surgery’) NOT ‘drug’) NOT ‘pharmacotherapy’) NOT ‘antidepressant’)
NOT ‘caregiver’[Title/Abstract]) NOT ‘prevalence’) NOT ‘risk factors’) NOT ‘case report’) NOT ‘acupuncture’)) NOT relationship[Title/Abstract])
NOT ‘serotonin reuptake inhibitor’) NOT etiology[Title/Abstract]) NOT screening[Title/Abstract]) NOT ‘pharmacology’) NOT ‘drug therapy’
FILTER: humans
PsycINFO 1 traumatic brain injury.mp. or exp Traumatic Brain Injury/(12988)
2 exp Cognitive Impairment/or exp Brain Damage/or exp Alzheimer’s Disease/(70020)
3 exp Dementia/or exp Cerebrovascular Accidents/or exp Cerebral Ischemia/or Stroke.mp. (71050)
4 neurodegenerative disease.mp. or exp Neurodegenerative Diseases/(49039)
5 exp Aging/or exp Mini Mental State Examination/or exp Dementia with Lewy Bodies/or mmse.mp. (40902)
6 exp Brain Damage/or exp Head Injuries/or brain injury.mp. (28035)
7 1 or 2 or 3 or 4 or 5 or 6 (156147)
8 therapy.mp. or exp Treatment/(509218)
9 intervention.mp. or exp Intervention/(157539)
10 program.mp. (137493)
11 8 or 9 or 10 (685772)
12 depress$.ti,ab. (182823)
13 7 and 11 and 12 (5006)
14 exp Electroconvulsive Shock Therapy/or exp Electroconvulsive Shock/or electroconvulsive.mp. (5620)
EMBASE 1 cognitive impairment.mp. or cognitive defect/(110884)
2 exp brain damage/(18604)
3 traumatic brain injury.mp. or exp brain injury/or exp traumatic brain injury/or exp head injury/(207692)
4 neurodegenerative disease.mp. or exp degenerative disease/(375596)
5 exp aging/or aging.mp. (412945)
6 mmse.mp. or exp Mini Mental State Examination/(21451)
7 exp ‘mixed depression and dementia’/or exp senile dementia/or dementia.mp. or exp dementia/or exp HIV associated dementia/(236836)
8 1 or 2 or 3 or 4 or 5 or 6 or 7 (1094564)
9 exp therapy/or therapy.mp. (6536263)
10 intervention.mp. or exp intervention study/(474236)
11 exp education program/or exp health program/or exp program impact/or exp program efficacy/or exp program evaluation/or program.mp.
or exp program feasibility/or exp program effectiveness/(606821)
12 9 or 10 or 11 (7082345)
13 depress$.ti,ab. (378701)
14 8 and 12 and 13 (18684)
15 drug therapy.mp. or exp drug therapy/(1682801)
16 antidepressant.mp. or exp antidepressant agent/(305303)
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Table 1 Database-specific search strategies (Continued)
17 exp risperidone/or exp clozapine/or exp quetiapine/or exp ziprasidone/or exp haloperidol/or exp chlorpromazine/or exp olanzapine/or
exp neuroleptic agent/or exp atypical antipsychotic agent/or antipsychotic.mp. (204343)
18 exp electroconvulsive therapy unit/or exp electroconvulsive therapy/or electroconvulsive.mp. (16851)
19 caregiver.ti,ab. (18046)
20 exp epidemiology/or epidemiology.mp. (2037231)







28 deep brain stimulation.mp. or exp brain depth stimulation/(24416)
29 surgery.mp. or exp surgery/(3551586)
30 marker.ti,ab. (317173)
31 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 (8808822)
32 14 not 31 (5012)
33 case report/(1879027)
34 32 not 33 (4829)
35 association.ti,ab. (1074371)
36 34 not 35 (4322)
CINAHL ( (MH ‘Brain Injuries+’) OR (MH ‘Delirium, Dementia, Amnestic, Cognitive Disorders+’) OR (MH ‘Cognition Disorders+’) OR (MH ‘Neurodegenerative
Diseases+’) OR (MH ‘Aging+’) OR (MH ‘Dementia+’) OR (MH ‘Dementia, Vascular+’) OR (MH ‘Dementia, Multi-Infarct’) OR (MH ‘AIDS Dementia
Complex’) OR (MH ‘Lewy Body Disease’) OR (MH ‘Dementia, Senile+’) OR (MH ‘Dementia, Presenile+’) ) AND ( ‘therapy’ OR (MH ‘Experimental
Studies+’) OR ‘intervention’ OR (MH ‘Program Implementation’) OR (MH ‘Program Evaluation’) OR ‘program’ OR (MH ‘Therapeutic Trials’) OR
‘therapeutic’ ) AND AB ( (MH ‘Depression+’) OR (MH ‘Self-Rating Depression Scale’) OR (MH ‘Hamilton Rating Scale for Depression’) OR (MH
‘Geriatric Depression Scale’) OR (MH ‘Edinburgh Postnatal Depression Scale’) OR (MH ‘Death Depression Scale’) OR (MH ‘Center for
Epidemiological Studies Depression Scale’) OR (MH ‘Beck Depression Inventory, Revised Edition’) ) NOT ( (MH ‘Epidemiology+’) OR (MH
‘Epidemiological Research+’) OR (MH ‘Risk Factors+’) OR (MH ‘Acupuncture+’) OR (MH ‘Surgery, Operative+’) OR (MH ‘Drug Screening Assays,
Antitumor’) OR (MH ‘Drug Evaluation, Preclinical’) OR (MH ‘Drug Rehabilitation Programs+’) OR (MH ‘Drug Design’) OR (MH ‘Drug
Compounding’) OR (MH ‘Antidepressive Agents+’) OR (MH ‘Antidepressive Agents, Tricyclic+’) OR (MH ‘Antidepressive Agents, Second
Generation+’) OR (MH ‘Electroconvulsive Therapy’) OR (MH ‘Deep Brain Stimulation’) OR (MH ‘Case Studies’) OR (MH ‘Gene Expression’)
OR (MH ‘Mutation+’) OR (MH ‘Genes+’) OR (MH ‘Drug Therapy+’) OR (MH ‘Hemodialysis+’) OR (MH ‘Prevalence’) OR (MH ‘Cross
Sectional Studies’) OR (MH ‘Surveys+’))////LIMITS: English language; human; peer-reviewed; language: English; age groups: adolescent:
13 to 18 years, adult: 19 to 44 years, middle aged: 45 to 64 years, aged: 65+ years, aged, 80 and over
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available, the mean change score (changes from baseline)
will be reported instead of follow-up scores. The second-
ary outcome of ‘adverse events’ will be analysed as a di-
chotomous outcome and expressed as a risk ratio (RR)
with 95% confidence intervals.Assessment of heterogeneity
Given the diverse populations and interventions that we
anticipate will be included in the review, we will test the
degree of heterogeneity between studies first by visually
inspecting graphs between studies and then using the χ2
test and I2 statistic in RevMan. If substantial degrees of
heterogeneity are found (χ2 P < 0.1; I2 > 0.5) [42], we will
pool studies using a random, rather than fixed, effectmodel and will explore the reasons for the heterogeneity
using sub-group analyses.Assessment of publication bias
A funnel plot will be prepared if there are a sufficient
number of studies (≥10) by plotting trial effect against
standard error [43]. Possible reasons for any asymmetry
will be discussed.Data synthesis
Studies will be categorized according to intervention
type. It is anticipated that potential categories may
broadly include 1) cognitive rehabilitation (e.g. memory
training, cognitive stimulation therapy, cognitive train-
ing, neuropsychological training, neurorehabilitation),
Figure 1 Flowchart outlining study selection process. The study process is comprised of four steps: identification, screening, eligibility and
final inclusion. Identification of studies will be primarily through the electronic literature search. Screening will involve title screening and removal
of duplicate records. Assessing eligibility will involve three steps: phase one abstract screening (applying the primary selection criteria), phase two
abstract screening (applying the secondary selection criteria) and full-text screening. Studies that pass all phases of eligibility screening will be
included in the review.
Topolovec-Vranic et al. Systematic Reviews  (2015) 4:42 Page 8 of 112) psychotherapy (e.g. cognitive behavioural therapy, inter-
personal therapy, problem-solving therapy, supportive
therapy, counselling, social skills training), 3) psychoedu-
cation, 4) exercise/physical activity and 5) others. The
studies within each intervention category will then be
summarized. Evidence from RCT and non-RCTs will be
presented separately rather than combined [44,45]. As
our review will cut across various clinical populations
and include many different types of interventions, care-
ful consideration will be given as to whether conduct-
ing a meta-analysis will be appropriate. As discussed in
the EPOC resources for review authors, calculation of
an average effect across studies may be meaningless if
there are ‘differences in populations, interventions,
comparisons or methods’ [46]. If there is a sufficient
pool of studies with comparable methodology and quality,a meta-analysis will be conducted using RevMan in
accordance with the statistical guidelines presented in
the Cochrane Handbook for Systematic Reviews of
Interventions (version 5.1.0) [42].
If a meta-analysis is deemed inappropriate, we will re-
port plain language summaries with the ‘worksheets for
preparing summary of findings tables using GRADE’ [47].
This tool will also enable us to assess the quality of evi-
dence for each outcome with the GRADE system [48]. For
each category of intervention, we will summarize the cat-
egory as a whole, and any variations/adaptations to the in-
terventions will be noted. A comparison of the similarities
and differences among studies with effective versus inef-
fective interventions will be summarized. This step will be
done to identify recurring elements of successful versus
unsuccessful interventions (e.g. modifications made to a
Topolovec-Vranic et al. Systematic Reviews  (2015) 4:42 Page 9 of 11standardized treatment protocol, involvement of care-
givers) and/or characteristics of studies that assessed suc-
cessful versus unsuccessful interventions (e.g. with respect
to sample size, quality, whether or not depression was a
primary outcome measure etc.).
Subgroup analysis
For outcome data at follow-up time points (when avail-
able), we will group the time periods as follows: baseline
(0 to 3 months), medium-term (3 to 6 months) and
long-term follow-up (greater than 6 months) [49]. We
will conduct subgroup analyses to identify whether there
are differences in depression change scores based on the
duration and/or frequency of the intervention, between
patients with mild/moderate versus severe cognitive im-
pairment or across clinical populations.
Sensitivity analysis
We will assess whether including or excluding lower
quality studies or those with higher risk of bias affects
the comparison between groups.
Discussion
Several possible challenges are anticipated with this re-
view. In order to inform the design of the planned
intervention program, we aim to be comprehensive in
the identification of interventions that are effective for
the treatment of depression for individuals with cogni-
tive impairment. Thus, it is possible that a large, un-
manageable number of relevant articles will be
identified. However, given that only eight studies of
psychotherapeutic or rehabilitation interventions for
depression for patients with TBI were identified by
Fann et al. [17] and only three studies were identified
with a non-pharmacological intervention for depression
after mild TBI in a more recent meta-analysis [50], it is
unlikely that the body of literature to review will be
overly extensive. Note, neither of these reviews exam-
ined the issue of cognitive impairment.
A second potential challenge may arise in the inclu-
sion/exclusion criteria related to cognitive impairment.
We recognize that a large number of health-related and
other (e.g. substance use) conditions/factors may result
in cognitive impairment. However, we are aiming to cap-
ture interventions that have been shown to be effective
in individuals with acquired brain injuries or neurode-
generative processes, our particular populations of inter-
est. Any articles that the reviewers are uncertain about
will be discussed by the study team to achieve consensus
regarding its inclusion in the review.
We also anticipate that the decision to include a wide
range of study designs in this review may render it dif-
ficult to effectively compare the results from studies
with drastically differing methodological quality. Toaccommodate our aim to be inclusive of the types of in-
terventions that exist and have been used with individ-
uals with cognitive impairments, we will include both
RCT and non-RCTs in the analyses (although separ-
ately), as well as uncontrolled studies in an Appendix.
This will allow for the identification of newer interven-
tions which may be currently only undergoing their
piloting phase and have not yet had the opportunity to
be assessed in the form of an RCT. Although these lat-
ter interventions are unlikely to be included in the
planned intervention, they will be noted and tracked
for possible future iterations of the program. Further-
more, we anticipate that assessing the risk of bias and
quality of evidence will facilitate the process of placing
into context the strength of evidence provided by each
included article. In including a variety of study designs,
we will be able to compare and contrast the interven-
tions with the largest treatment effects and supporting
strength of evidence. By doing so, we may be able to
identify recurring elements of the most effective inter-
ventions (e.g. modifications made to a standardized
treatment protocol, involvement of caregivers) and/or
characteristics of studies that differentiated successful
versus unsuccessful interventions (e.g. sample size,
quality, whether or not depression was a primary out-
come measure).
Another potential limitation of the review is language
bias, as only studies published in English will be in-
cluded in this review. This limitation will be kept in
mind when interpreting the results of the review.
Our overall goal is to identify interventions that will
be amenable to delivery via technologies such as the
internet and/or mobile devices (e.g. smart phones,
tablets, PCs). However, as technology itself is consist-
ently changing, it is difficult to place concrete limits on
whether or not an intervention is amenable to technol-
ogy. We have decided to focus on developing a psycho-
therapeutic and/or behavioural technology-delivered
intervention, as the feasibility of developing such inter-
ventions has already been demonstrated through cur-
rently available online psychotherapy interventions for
depression for the general population [51-53]. Exercise
therapy/physical activity interventions will also be included
in the review as a growing body of literature suggests that
they may be effectively delivered via technology [54-57].
Nevertheless, in the future, it may also be promising to in-
vestigate the potential for adapting other forms of therapy,
such as music therapy, into a technology-based format for
treating depression in both general populations and/or
those with cognitive impairments.
The knowledge gained from this systematic review will
be used by the research team to build the evidence base
upon which we will develop the planned technology-
based intervention program for depression for adults
Topolovec-Vranic et al. Systematic Reviews  (2015) 4:42 Page 10 of 11with cognitive impairments. The findings will also be
disseminated through peer-review publication, which
will inform clinical decision-making regarding individ-
uals with cognitive impairment. In particular, bringing
together evidence from various clinical populations
with cognitive impairment may help to inform clinicians
and researchers and bring to light other potential non-
pharmacological treatments for exploration with patients
with cognitive impairment and vice-versa.
Additional files
Additional file 1: Full-text-screening form. Each column of the form
corresponds to each inclusion/exclusion criteria outlined in the methods
of the study protocol. The green cells refer to inclusion criteria, whereas
the red cells refer to exclusion criteria.
Additional file 2: Data abstraction form. The piloted form to extract
full data from included studies, in which the purple cells refer to
intervention details, blue cells refer to study sample characteristics, and
orange cells refer to outcomes on depressive symptomatology and
adverse events.
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